This page contains brief information about abemaciclib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Abemaciclib is approved to treat:
- Breast cancer that is hormone receptor positive (HR+) and HER2 negative (HER2-) and is advanced or has metastasized (spread to other parts of the body).
Abemaciclib is also being studied in the treatment of other types of cancer.
More About Abemaciclib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Abemaciclib - Check for trials from NCI's list of cancer clinical trials now accepting patients.